标题
Clinical determinants of calcineurin inhibitor disposition: a mechanistic review
作者
关键词
-
出版物
DRUG METABOLISM REVIEWS
Volume 48, Issue 1, Pages 88-112
出版商
Informa UK Limited
发表日期
2016-02-25
DOI
10.3109/03602532.2016.1151037
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Progressive decline in tacrolimus clearance after renal transplantation is partially explained by decreasing CYP3A4 activity and increasing haematocrit
- (2015) Hylke de Jonge et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- The donor ABCB1 (MDR-1) C3435T polymorphism is a determinant of the graft glomerular filtration rate among tacrolimus treated kidney transplanted patients
- (2015) Beatriz Tavira et al. JOURNAL OF HUMAN GENETICS
- The Functional Implications of Common Genetic Variation in CYP3A5 and ABCB1 in Human Proximal Tubule Cells
- (2015) Noël Knops et al. MOLECULAR PHARMACEUTICS
- Supra-therapeutic tacrolimus concentrations associated with concomitant nicardipine in pediatric liver transplant recipients
- (2015) Amanda L. Hurst et al. PEDIATRIC TRANSPLANTATION
- Effects ofCYP3A5genotypes,ABCB1 C3435TandG2677T/Apolymorphism on pharmacokinetics of Tacrolimus in Chinese adult liver transplant patients
- (2015) LiQin Zhu et al. XENOBIOTICA
- Gut Microbiota and Tacrolimus Dosing in Kidney Transplantation
- (2015) John R. Lee et al. PLoS One
- Improved prediction of tacrolimus concentrations early after kidney transplantation using theory-based pharmacokinetic modelling
- (2014) Elisabet Størset et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Assessment of Tacrolimus Absorption From the Human Intestinal Tract: Open-Label, Randomized, 4-Way Crossover Study
- (2014) Daisuke Tsunashima et al. CLINICAL THERAPEUTICS
- Hepatic early inflammation induces downregulation of hepatic cytochrome P450 expression and metabolic activity in the dextran sulfate sodium-induced murine colitis
- (2014) Yoshiki Kusunoki et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Pomelo enhances cyclosporine bioavailability in healthy male thai volunteers
- (2014) Wirin Anlamlert et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Genetic variance in ABCB1 and CYP3A5 does not contribute toward the development of chronic kidney disease after liver transplantation
- (2014) Özlem Tapirdamaz et al. Pharmacogenetics and Genomics
- Significant Tacrolimus and Dronedarone Interaction in a Kidney Transplant Recipient
- (2014) Mónica Marin-Casino et al. TRANSPLANTATION
- Tacrolimus placental transfer at delivery and neonatal exposure through breast milk
- (2013) Songmao Zheng et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- The Role of Pharmacogenetics in the Disposition of and Response to Tacrolimus in Solid Organ Transplantation
- (2013) Dennis A. Hesselink et al. CLINICAL PHARMACOKINETICS
- Cometabolism of Microbes and Host: Implications for Drug Metabolism and Drug-Induced Toxicity
- (2013) H Li et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Importance of hematocrit for a tacrolimus target concentration strategy
- (2013) Elisabet Størset et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Effect of itraconazole on the concentrations of tacrolimus and cyclosporine in the blood of patients receiving allogeneic hematopoietic stem cell transplants
- (2013) Miho Nara et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Total plasma protein effect on tacrolimus elimination in kidney transplant patients – Population pharmacokinetic approach
- (2013) Bojana Golubović et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Molecular Docking Characterizes Substrate-Binding Sites and Efflux Modulation Mechanisms within P-Glycoprotein.
- (2013) Ricardo J. Ferreira et al. Journal of Chemical Information and Modeling
- Major Active Components in Grapefruit, Orange, and Apple Juices Responsible for OATP2B1-Mediated Drug Interactions
- (2013) Yoshiyuki Shirasaka et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Impact of CYP3A5 genotype on tacrolimus versus midazolam clearance in renal transplant recipients: new insights in CYP3A5-mediated drug metabolism
- (2013) Hylke de Jonge et al. PHARMACOGENOMICS
- Inclusion of CYP3A5 genotyping in a nonparametric population model improves dosing of tacrolimus early after transplantation
- (2013) Anders Åsberg et al. TRANSPLANT INTERNATIONAL
- CYP3A5 Gene Variation Influences Cyclosporine A Metabolite Formation and Renal Cyclosporine Disposition
- (2013) Songmao Zheng et al. TRANSPLANTATION
- Outcomes in African American Kidney Transplant Patients Receiving Tacrolimus and Mycophenolic Acid Immunosuppression
- (2013) Mohanram Narayanan et al. TRANSPLANTATION
- Effects ofNigella sativaandLepidium sativumon Cyclosporine Pharmacokinetics
- (2013) F. I. Al-Jenoobi et al. Biomed Research International
- Intestinal drug transporters: An overview
- (2012) Margarida Estudante et al. ADVANCED DRUG DELIVERY REVIEWS
- Lower Calcineurin Inhibitor Doses in Older Compared to Younger Kidney Transplant Recipients Yield Similar Troughs
- (2012) P. A. Jacobson et al. AMERICAN JOURNAL OF TRANSPLANTATION
- CYP3A-dependent drug metabolism is reduced in bacterial inflammation in mice
- (2012) AS Gandhi et al. BRITISH JOURNAL OF PHARMACOLOGY
- In Vivo CYP3A4 Activity, CYP3A5 Genotype, and Hematocrit Predict Tacrolimus Dose Requirements and Clearance in Renal Transplant Patients
- (2012) H de Jonge et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Measurement and Compartmental Modeling of the Effect of CYP3A5 Gene Variation on Systemic and Intrarenal Tacrolimus Disposition
- (2012) S Zheng et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Switching from intravenous to oral tacrolimus and voriconazole leads to a more pronounced drug–drug interaction
- (2012) Isabel Spriet et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Liquorice reduced cyclosporine bioavailability by activating P-glycoprotein and CYP 3A
- (2012) Yu-Chi Hou et al. FOOD CHEMISTRY
- Pharmacokinetic interaction between the hepatitis C virus protease inhibitor boceprevir and cyclosporine and tacrolimus in healthy volunteers
- (2012) Ellen Hulskotte et al. HEPATOLOGY
- Current Understanding of Drug Disposition in Kidney Disease
- (2012) Judith Naud et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Donor ABCB1 Variant Associates with Increased Risk for Kidney Allograft Failure
- (2012) J. Moore et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Cyclosporine Inhibition of Hepatic and Intestinal CYP3A4, Uptake and Efflux Transporters: Application of PBPK Modeling in the Assessment of Drug-Drug Interaction Potential
- (2012) Michael Gertz et al. PHARMACEUTICAL RESEARCH
- The effect of CYP3A5 6986A>G and ABCB1 3435C>T on tacrolimus dose-adjusted trough levels and acute rejection rates in renal transplant patients
- (2012) Salvatore Terrazzino et al. Pharmacogenetics and Genomics
- Pharmacokinetics of Tacrolimus During Pregnancy
- (2012) Songmao Zheng et al. THERAPEUTIC DRUG MONITORING
- Pharmacokinetics in Stable Kidney Transplant Recipients After Conversion From Twice-Daily to Once-daily Tacrolimus Formulations
- (2012) Johannes van Hooff et al. THERAPEUTIC DRUG MONITORING
- Impact of genetic polymorphisms on tacrolimus pharmacokinetics and the clinical outcome of renal transplantation
- (2012) Guillermo Gervasini et al. TRANSPLANT INTERNATIONAL
- Genetic and Clinical Determinants of Early, Acute Calcineurin Inhibitor-Related Nephrotoxicity
- (2012) Pamala A. Jacobson et al. TRANSPLANTATION
- Comparison of Pharmacokinetics and Pharmacogenetics of Once- and Twice-Daily Tacrolimus in the Early Stage After Renal Transplantation
- (2012) Takenori Niioka et al. TRANSPLANTATION
- Dosing equation for tacrolimus using genetic variants and clinical factors
- (2011) Chaitali Passey et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Influence of Cytochrome P450 3A5 (CYP3A5) Genetic Polymorphism on the Pharmacokinetics of the Prolonged-Release, Once-Daily Formulation of Tacrolimus in Stable Renal Transplant Recipients
- (2011) François Glowacki et al. CLINICAL PHARMACOKINETICS
- In Vivo CYP3A Activity Is Significantly Lower in Cyclosporine-Treated as Compared With Tacrolimus-Treated Renal Allograft Recipients
- (2011) H de Jonge et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Pharmacokinetic Differences Corroborate Observed Low Tacrolimus Dosage in Native American Renal Transplant Patients
- (2011) A. Grover et al. DRUG METABOLISM AND DISPOSITION
- Food-drug Interaction of Tacrolimus with Pomelo, Ginger, and Turmeric Juice in Rats
- (2011) Kanoko Egashira et al. Drug Metabolism and Pharmacokinetics
- Effects of Schisandra sphenanthera extract on the blood concentration of tacrolimus in renal transplant recipients
- (2011) Hua-Wen Xin et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Clinical and genetic factors affecting tacrolimus trough levels and drug-related outcomes in Korean kidney transplant recipients
- (2011) In-Wha Kim et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- The interactions of age, sex, body mass index, genetics, and steroid weight-based doses on tacrolimus dosing requirement after adult kidney transplantation
- (2011) P. Stratta et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Effect of telaprevir on the pharmacokinetics of cyclosporine and tacrolimus
- (2011) Varun Garg et al. HEPATOLOGY
- Citrus grandis Peel Increases the Bioavailability of Cyclosporine and Tacrolimus, Two Important Immunosuppressants, in Rats
- (2011) Shiuan-Pey Lin et al. JOURNAL OF MEDICINAL FOOD
- CYP3A5 and ABCB1 polymorphisms in donor and recipient: impact on Tacrolimus dose requirements and clinical outcome after renal transplantation
- (2011) François Glowacki et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Engraftment syndrome, but not acute GVHD, younger age, CYP3A5 or MDR1 polymorphisms, increases tacrolimus clearance in pediatric hematopoietic SCT
- (2010) R Yanagisawa et al. BONE MARROW TRANSPLANTATION
- Potential impact of cytochrome P450 3A5 in human liver on drug interactions with triazoles
- (2010) Hiroshi Yamazaki et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Evaluation of In Vivo P-Glycoprotein Phenotyping Probes
- (2010) Joseph D. Ma et al. CLINICAL PHARMACOKINETICS
- Effect of CYP3A and ABCB1 Single Nucleotide Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Calcineurin Inhibitors: Part II
- (2010) Christine E. Staatz et al. CLINICAL PHARMACOKINETICS
- Effect of CYP3A and ABCB1 Single Nucleotide Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Calcineurin Inhibitors: Part I
- (2010) Christine E. Staatz et al. CLINICAL PHARMACOKINETICS
- A prospective, open-label, observational clinical cohort study of the association between delayed renal allograft function, tacrolimus exposure, and CYP3A5 genotype in adult recipients
- (2010) Dirk R.J. Kuypers et al. CLINICAL THERAPEUTICS
- Voriconazole and itraconazole in lung transplant recipients receiving tacrolimus (FK 506): efficacy and drug interaction
- (2010) Mordechai R. Kramer et al. CLINICAL TRANSPLANTATION
- Association between renal function and CYP3A5 genotype in heart transplant recipients treated with calcineurin inhibitors
- (2010) Simon de Denus et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Cytochrome P450-mediated metabolism in the human gut wall
- (2010) Kirstin Thelen et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- CYP3A5andABCB1polymorphisms influence tacrolimus concentrations in peripheral blood mononuclear cells after renal transplantation
- (2010) Arnaud Capron et al. PHARMACOGENOMICS
- Effects of diltiazem on pharmacokinetics of tacrolimus in relation to CYP3A5 genotype status in renal recipients: from retrospective to prospective
- (2010) J-L Li et al. PHARMACOGENOMICS JOURNAL
- Effects of Silibinin, Inhibitor of CYP3A4 and P-Glycoprotein in vitro, on the Pharmacokinetics of Paclitaxel after Oral and Intravenous Administration in Rats
- (2010) Chong-Ki Lee et al. PHARMACOLOGY
- Tacrolimus Dose Requirements and CYP3A5 Genotype and the Development of Calcineurin Inhibitor-Associated Nephrotoxicity in Renal Allograft Recipients
- (2010) Dirk R J Kuypers et al. THERAPEUTIC DRUG MONITORING
- Case Report: Drug Interaction Between Tacrolimus and Amiodarone With QT Prolongation
- (2010) Cathy I. Burger et al. TRANSPLANTATION
- Reduced C0 Concentrations and Increased Dose Requirements in Renal Allograft Recipients Converted to the Novel Once-Daily Tacrolimus Formulation
- (2010) Hylke de Jonge et al. TRANSPLANTATION
- Pharmacokinetics for Once- Versus Twice-Daily Tacrolimus Formulations inDe NovoKidney Transplantation: A Randomized, Open-Label Trial
- (2009) Z. Wlodarczyk et al. AMERICAN JOURNAL OF TRANSPLANTATION
- A Population Pharmacokinetic Model of Ciclosporin Applicable for Assisting Dose Management of Kidney Transplant Recipients
- (2009) Pål Falck et al. CLINICAL PHARMACOKINETICS
- Influence of CYP3A5 and ABCB1 gene polymorphisms on calcineurin inhibitor-related neurotoxicity after hematopoietic stem cell transplantation
- (2009) Masakatsu Yanagimachi et al. CLINICAL TRANSPLANTATION
- Dual Mechanisms of CYP3A Protein Regulation by Proinflammatory Cytokine Stimulation in Primary Hepatocyte Cultures
- (2009) C.-M. Lee et al. DRUG METABOLISM AND DISPOSITION
- No impact of age on dose-adjusted pharmacokinetics of tacrolimus, mycophenolic acid and prednisolone 1 month after renal transplantation
- (2009) Masatomo Miura et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Co-administration of grapefruit juice increases bioavailability of tacrolimus in liver transplant patients: a prospective study
- (2009) Chang Liu et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Drug Interaction Between Tacrolimus and Carbamazepine in a Japanese Heart Transplant Recipient: A Case Report
- (2009) Kyoichi Wada et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Donor Age and Renal P-Glycoprotein Expression Associate with Chronic Histological Damage in Renal Allografts
- (2009) M. Naesens et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Influence of ABCB1 genetic polymorphisms on cyclosporine intracellular concentration in transplant recipients
- (2009) Séverine Crettol et al. Pharmacogenetics and Genomics
- Optimizing Pediatric Dosing: A Developmental Pharmacologic Approach
- (2009) Gail D Anderson et al. PHARMACOTHERAPY
- Effect of berberine on the pharmacokinetics of substrates of CYP3A and P-gp
- (2009) W. Qiu et al. PHYTOTHERAPY RESEARCH
- Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding
- (2009) S. G. Aller et al. SCIENCE
- Tacrolimus dosage requirements in living donor liver transplant recipients with small-for-size grafts
- (2009) Fei Liu et al. WORLD JOURNAL OF GASTROENTEROLOGY
- The Influence of CYP3A5 Genotype on Dexamethasone Induction of CYP3A Activity in African Americans
- (2008) P. J. Roberts et al. DRUG METABOLISM AND DISPOSITION
- Serum cyclosporine level and orange juice in pediatric renal-transplanted patients
- (2008) Hadi Sorkhi et al. PEDIATRIC TRANSPLANTATION
- Effects of CYP3A5 and MDR1 single nucleotide polymorphisms on drug interactions between tacrolimus and fluconazole in renal allograft recipients
- (2008) Dirk R. Kuypers et al. Pharmacogenetics and Genomics
- CYP3A5 genotype is not associated with a higher risk of acute rejection in tacrolimus-treated renal transplant recipients
- (2008) Dennis A. Hesselink et al. Pharmacogenetics and Genomics
- The influence of C3435T polymorphism of ABCB1 gene on penetration of phenobarbital across the blood–brain barrier in patients with generalized epilepsy
- (2008) Silvio Basic et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Reduced Elimination of Cyclosporine A in Elderly (>65 Years) Kidney Transplant Recipients
- (2008) Pål Falck et al. TRANSPLANTATION
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started